March 12, 2024 Comments Off on New patent for Strongbridge drug RECORLEV Posted in: Patent Added Annual Drug Patent Expirations for RECORLEV Recorlev is a drug marketed by Strongbridge and is included in one NDA. It is available from one supplier. There are seven patents protecting…
The post New patent for Strongbridge drug RECORLEV appeared first…
March 12, 2024 Comments Off on New patent for Oyster Point drug TYRVAYA Posted in: Patent Added Annual Drug Patent Expirations for TYRVAYA Tyrvaya is a drug marketed by Oyster Point Pharma and is included in one NDA. It is available from one supplier. There are six…
The post New patent for Oyster Point drug TYRVAYA appeared first on DrugPatentWat…